Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
Silvestris N, Argentiero A, Natalicchio A, D'Oronzo S, Beretta GD, Acquati S, Adinolfi V, Di Bartolo P, Danesi R, Faggiano A, Ferrari P, Gallo M, Gori S, Morviducci L, Russo A, Tuveri E, Zatelli MC, Montagnani M, Giorgino F. Silvestris N, et al. ESMO Open. 2021 Jun;6(3):100153. doi: 10.1016/j.esmoop.2021.100153. Epub 2021 May 10. ESMO Open. 2021. PMID: 33984679 Free PMC article. Review.
p53 as the main traffic controller of the cell signaling network.
Sebastian S, Azzariti A, Silvestris N, Porcelli L, Russo A, Paradiso A. Sebastian S, et al. Among authors: silvestris n. Front Biosci (Landmark Ed). 2010 Jun 1;15(3):1172-90. doi: 10.2741/3669. Front Biosci (Landmark Ed). 2010. PMID: 20515749 Free article. Review.
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines.
Silvestris N, Del Re M, Azzariti A, Maiello E, Lombardi L, Cinieri S, Guarini A, Brunetti AE, Delcuratolo S, De Vita F, Pisconti S, Danesi R, Colucci G. Silvestris N, et al. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S111-7. doi: 10.1517/14728222.2011.652089. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443211 Review.
Pharmacogenomics of cetuximab in metastatic colorectal carcinoma.
Silvestris N, Vincenzi B, Brunetti AE, Loupakis F, Dell'Aquila E, Russo A, Scartozzi M, Giampieri R, Cascinu S, Lorusso V, Tonini G, Falcone A, Santini D. Silvestris N, et al. Pharmacogenomics. 2014 Sep;15(13):1701-15. doi: 10.2217/pgs.14.124. Pharmacogenomics. 2014. PMID: 25410895 Review.
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy.
Bronte G, Bronte E, Novo G, Pernice G, Lo Vullo F, Musso E, Bronte F, Gulotta E, Rizzo S, Rolfo C, Silvestris N, Bazan V, Novo S, Russo A. Bronte G, et al. Among authors: silvestris n. Expert Opin Drug Saf. 2015 Feb;14(2):253-67. doi: 10.1517/14740338.2015.986092. Epub 2014 Dec 13. Expert Opin Drug Saf. 2015. PMID: 25494575 Review.
390 results